STERIS (STE) Stock Price, News & Analysis

Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Key Stats

• Today's Range: $231.82 to $234.41
• 50-Day Range: $227.20 to $247.17
• 52-Week Range: $195.47 to $248.24
• Volume: 109,221 shs
• Average Volume: 471,272 shs
• Market Capitalization: $23.02 billion
• P/E Ratio: 61.12
• Dividend Yield: 0.98%
• Price Target: $246.00
• Consensus Rating: Moderate Buy

STERIS Stock Analysis - MarketRank™

STERIS scored higher than 94% of companies evaluated by MarketBeat, and ranked 81st out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

STERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

STERIS has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 9.27%

Earnings Growth

Earnings for STERIS are expected to grow by 9.27% in the coming year, from $9.06 to $9.90 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of STERIS is 61.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of STERIS is 61.14, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 141.43.

Price to Book Value per Share Ratio

STERIS has a P/B Ratio of 3.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.49% of the float of STERIS has been sold short.

Short Interest Ratio / Days to Cover

STERIS has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STERIS has recently decreased by 20.22%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

STERIS has a dividend yield of 0.95%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

STERIS has been increasing its dividend for 20 years.

Dividend Coverage

The dividend payout ratio of STERIS is 59.69%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, STERIS will have a dividend payout ratio of 23.03% next year. This indicates that STERIS will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -2.00

Percentage of Shares Shorted

1.49% of the float of STERIS has been sold short.

Short Interest Ratio / Days to Cover

STERIS has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STERIS has recently decreased by 20.22%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.12

News Sentiment

STERIS has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 19 news articles for STERIS this week, compared to 7 articles on an average week.

Search Interest

Only 8 people have searched for STE on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added STERIS to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, STERIS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,876,373.00 in company stock.

Percentage Held by Insiders

Only 1.14% of the stock of STERIS is held by insiders.

Percentage Held by Institutions

94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

STE Stock Analysis - Frequently Asked Questions

How have STE shares performed this year?

STERIS's stock was trading at $219.85 at the start of the year. Since then, STE shares have increased by 6.2% and is now trading at $233.55.
View the best growth stocks for 2024 here.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) announced its quarterly earnings results on Tuesday, August, 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping analysts' consensus estimates of $1.98 by $0.16. The business's revenue was down .4% on a year-over-year basis.
Read the conference call transcript.

Who are STERIS's major shareholders?

Top institutional shareholders of STERIS include Czech National Bank (0.02%) and Central Pacific Bank Trust Division. Insiders that own company stock include Michael J Tokich, John Adam Zangerle, Mohsen Sohi, Cary L Majors, Renato Tamaro, Jacqueline B Kosecoff, Karen L Burton and Cynthia L Feldmann.
View institutional ownership trends.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT) and Pfizer (PFE).

Company Calendar

• Last Earnings: 8/06/2024
• Ex-Dividend for 9/20 Dividend: 9/05/2024
• Dividend Payable: 9/20/2024
• Today: 10/03/2024
• Next Earnings (Estimated): 11/05/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:STE
• CUSIP: 85915210
• CIK: 1624899
• Web: www.steris.com
• Phone: (440) 354-2600
• Fax: 440-639-4457
• Employees: 18,179
• Year Founded: 1987

Price Target and Rating

• Average Stock Price Target: $246.00
• High Stock Price Target: $265.00
• Low Stock Price Target: $215.00
• Potential Upside/Downside: +4.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.82
• Trailing P/E Ratio: 61.45
• Forward P/E Ratio: 25.91
• P/E Growth: N/A
• Net Income: $378.24 million
• Net Margins: 7.36%
• Pretax Margin: 13.08%
• Return on Equity: 13.85%
• Return on Assets: 7.99%

Debt

• Debt-to-Equity Ratio: 0.35
• Current Ratio: 2.33
• Quick Ratio: 1.49

Sales & Book Value

• Annual Sales: $5.14 billion
• Price / Sales: 4.50
• Cash Flow: $13.78 per share
• Price / Cash Flow: 17.03
• Book Value: $63.91 per share
• Price / Book: 3.67

Miscellaneous

• Outstanding Shares: 98,620,000
• Free Float: 97,726,000
• Market Cap: $23.15 billion
• Optionable: Optionable
• Beta: 0.83